Literature DB >> 33415312

Toward improved models of human cancer.

Bryan E Welm1, Christos Vaklavas2, Alana L Welm3.   

Abstract

Human cancer is a complex and heterogeneous collection of diseases that kills more than 18 million people every year worldwide. Despite advances in detection, diagnosis, and treatments for cancers, new strategies are needed to combat deadly cancers. Models of human cancer continue to evolve for preclinical research and have culminated in patient-derived systems that better represent the diversity and complexity of cancer. Still, no model is perfect. This Perspective attempts to address ways that we can improve the clinical translatability of models used for cancer research, from the point of view of researchers who mainly conduct cancer studies in vivo.
© 2021 Author(s).

Entities:  

Year:  2021        PMID: 33415312      PMCID: PMC7785323          DOI: 10.1063/5.0030534

Source DB:  PubMed          Journal:  APL Bioeng        ISSN: 2473-2877


  33 in total

Review 1.  The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research.

Authors:  Logan C DeBord; Ravi R Pathak; Mariana Villaneuva; Hsuan-Chen Liu; Daniel A Harrington; Wendong Yu; Michael T Lewis; Andrew G Sikora
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

2.  Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.

Authors:  Chantal Pauli; Benjamin D Hopkins; Davide Prandi; Reid Shaw; Tarcisio Fedrizzi; Andrea Sboner; Verena Sailer; Michael Augello; Loredana Puca; Rachele Rosati; Terra J McNary; Yelena Churakova; Cynthia Cheung; Joanna Triscott; David Pisapia; Rema Rao; Juan Miguel Mosquera; Brian Robinson; Bishoy M Faltas; Brooke E Emerling; Vijayakrishna K Gadi; Brady Bernard; Olivier Elemento; Himisha Beltran; Francesca Demichelis; Christopher J Kemp; Carla Grandori; Lewis C Cantley; Mark A Rubin
Journal:  Cancer Discov       Date:  2017-03-22       Impact factor: 39.397

3.  Is Precision Medicine an Oxymoron?

Authors:  S Gail Eckhardt; Christopher Lieu
Journal:  JAMA Oncol       Date:  2019-02-01       Impact factor: 31.777

Review 4.  Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery.

Authors:  Fleur Weeber; Salo N Ooft; Krijn K Dijkstra; Emile E Voest
Journal:  Cell Chem Biol       Date:  2017-07-27       Impact factor: 8.116

5.  Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment.

Authors:  Lei Wang; Huan Chen; Fei Fei; Xianfeng He; Shaoyang Sun; Kunpeng Lv; Bo Yu; Jiang Long; Xu Wang
Journal:  J Vis Exp       Date:  2019-04-30       Impact factor: 1.355

Review 6.  Concepts in Cancer Modeling: A Brief History.

Authors:  Renee M Thomas; Terry Van Dyke; Glenn Merlino; Chi-Ping Day
Journal:  Cancer Res       Date:  2016-09-30       Impact factor: 12.701

Review 7.  Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity.

Authors:  John D Martin; Dai Fukumura; Dan G Duda; Yves Boucher; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

8.  Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies.

Authors:  V M Weaver; O W Petersen; F Wang; C A Larabell; P Briand; C Damsky; M J Bissell
Journal:  J Cell Biol       Date:  1997-04-07       Impact factor: 10.539

Review 9.  Pre-clinical modeling of cutaneous melanoma.

Authors:  Vito W Rebecca; Rajasekharan Somasundaram; Meenhard Herlyn
Journal:  Nat Commun       Date:  2020-06-05       Impact factor: 14.919

10.  Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.

Authors:  Hiroshi Maeda; Mahin Khatami
Journal:  Clin Transl Med       Date:  2018-03-01
View more
  5 in total

1.  Toward improved models of human cancer: Two perspectives.

Authors:  Roger D Kamm
Journal:  APL Bioeng       Date:  2021-02-19

2.  Erratum: "Toward improved models of human cancer" [APL Bioeng. 5, 010901 (2021)].

Authors:  Bryan E Welm; Christos Vaklavas; Alana L Welm
Journal:  APL Bioeng       Date:  2021-06-02

3.  Editorial Series conclusion and journal outlook.

Authors:  Justin J Cooper-White
Journal:  APL Bioeng       Date:  2022-08-19

4.  A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma.

Authors:  Mai Q Nguyen; Nicole A Wilski; Timothy J Purwin; Weijia Cai; Mégane Vernon; Manoela Tiago; Andrew E Aplin
Journal:  Cancer Res       Date:  2022-07-18       Impact factor: 13.312

Review 5.  Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations.

Authors:  Anthony Letai; Patrick Bhola; Alana L Welm
Journal:  Cancer Cell       Date:  2021-12-23       Impact factor: 31.743

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.